| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 8.63e-05 | 775 | 38 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.38e-04 | 614 | 38 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.50e-04 | 839 | 38 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.51e-04 | 840 | 38 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.51e-04 | 840 | 38 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.70e-04 | 441 | 38 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | helicase activity | 2.26e-04 | 158 | 38 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.38e-04 | 78 | 38 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 4.72e-04 | 80 | 38 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 8.08e-04 | 1356 | 38 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | histone reader activity | 1.11e-03 | 26 | 38 | 2 | GO:0140566 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.30e-03 | 1160 | 38 | 8 | GO:0030674 | |
| GeneOntologyMolecularFunction | histone binding | 1.57e-03 | 265 | 38 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.25e-03 | 37 | 38 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.76e-03 | 41 | 38 | 2 | GO:0140463 | |
| GeneOntologyBiologicalProcess | late viral transcription | 1.87e-05 | 4 | 37 | 2 | GO:0019086 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription from RNA polymerase II promoter by glucose | 6.54e-05 | 7 | 37 | 2 | GO:0000432 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by glucose | 8.71e-05 | 8 | 37 | 2 | GO:0046016 | |
| GeneOntologyBiologicalProcess | regulation of transcription from RNA polymerase II promoter by glucose | 8.71e-05 | 8 | 37 | 2 | GO:0000430 | |
| GeneOntologyBiologicalProcess | carbon catabolite activation of transcription from RNA polymerase II promoter | 8.71e-05 | 8 | 37 | 2 | GO:0000436 | |
| GeneOntologyBiologicalProcess | carbon catabolite regulation of transcription from RNA polymerase II promoter | 1.12e-04 | 9 | 37 | 2 | GO:0000429 | |
| GeneOntologyBiologicalProcess | carbon catabolite activation of transcription | 1.12e-04 | 9 | 37 | 2 | GO:0045991 | |
| GeneOntologyBiologicalProcess | carbon catabolite regulation of transcription | 1.40e-04 | 10 | 37 | 2 | GO:0045990 | |
| GeneOntologyBiologicalProcess | regulation of transcription by glucose | 2.04e-04 | 12 | 37 | 2 | GO:0046015 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 5.30e-04 | 210 | 37 | 4 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 5.79e-04 | 215 | 37 | 4 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 5.79e-04 | 215 | 37 | 4 | GO:0060285 | |
| MousePheno | sporadic seizures | 2.79e-05 | 27 | 31 | 3 | MP:0000951 | |
| MousePheno | pericardial effusion | 1.00e-04 | 111 | 31 | 4 | MP:0005312 | |
| Domain | P-loop_NTPase | 2.45e-05 | 848 | 36 | 9 | IPR027417 | |
| Domain | Helicase_C | 5.21e-05 | 107 | 36 | 4 | PF00271 | |
| Domain | HELICc | 5.21e-05 | 107 | 36 | 4 | SM00490 | |
| Domain | Helicase_C | 5.40e-05 | 108 | 36 | 4 | IPR001650 | |
| Domain | - | 5.60e-05 | 109 | 36 | 4 | 4.10.280.10 | |
| Domain | HELICASE_CTER | 5.60e-05 | 109 | 36 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.60e-05 | 109 | 36 | 4 | PS51192 | |
| Domain | DEXDc | 5.60e-05 | 109 | 36 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.80e-05 | 110 | 36 | 4 | IPR014001 | |
| Domain | HLH | 6.01e-05 | 111 | 36 | 4 | PF00010 | |
| Domain | HLH | 7.14e-05 | 116 | 36 | 4 | SM00353 | |
| Domain | BHLH | 7.38e-05 | 117 | 36 | 4 | PS50888 | |
| Domain | bHLH_dom | 7.63e-05 | 118 | 36 | 4 | IPR011598 | |
| Domain | DEAD | 3.73e-04 | 73 | 36 | 3 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.73e-04 | 73 | 36 | 3 | IPR011545 | |
| Domain | - | 4.78e-04 | 746 | 36 | 7 | 3.40.50.300 | |
| Domain | DEAD_ATP_HELICASE | 1.62e-03 | 31 | 36 | 2 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 1.84e-03 | 33 | 36 | 2 | IPR000629 | |
| Domain | EF-hand-dom_pair | 2.18e-03 | 287 | 36 | 4 | IPR011992 | |
| Domain | RNA_helicase_DEAD_Q_motif | 2.31e-03 | 37 | 36 | 2 | IPR014014 | |
| Domain | Q_MOTIF | 2.31e-03 | 37 | 36 | 2 | PS51195 | |
| Domain | EF_Hand_1_Ca_BS | 4.60e-03 | 175 | 36 | 3 | IPR018247 | |
| Domain | Zinc_finger_PHD-type_CS | 6.96e-03 | 65 | 36 | 2 | IPR019786 | |
| Domain | EF_HAND_1 | 7.03e-03 | 204 | 36 | 3 | PS00018 | |
| Domain | CH | 8.71e-03 | 73 | 36 | 2 | PS50021 | |
| Domain | PHD | 9.18e-03 | 75 | 36 | 2 | PF00628 | |
| Domain | CH-domain | 9.18e-03 | 75 | 36 | 2 | IPR001715 | |
| Domain | EF_HAND_2 | 9.87e-03 | 231 | 36 | 3 | PS50222 | |
| Domain | EF_hand_dom | 9.99e-03 | 232 | 36 | 3 | IPR002048 | |
| Domain | Znf_PHD-finger | 1.01e-02 | 79 | 36 | 2 | IPR019787 | |
| Domain | PHD | 1.27e-02 | 89 | 36 | 2 | SM00249 | |
| Domain | Znf_PHD | 1.33e-02 | 91 | 36 | 2 | IPR001965 | |
| Domain | - | 1.37e-02 | 261 | 36 | 3 | 1.10.238.10 | |
| Domain | ZF_PHD_2 | 1.44e-02 | 95 | 36 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.47e-02 | 96 | 36 | 2 | PS01359 | |
| Pubmed | 3.05e-09 | 506 | 38 | 9 | 30890647 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX23 ACIN1 PHF14 ZFR ZZZ3 USF1 SRCAP USF2 PHF3 DDX54 RAVER1 | 8.65e-08 | 1294 | 38 | 11 | 30804502 |
| Pubmed | 1.68e-07 | 808 | 38 | 9 | 20412781 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.57e-07 | 608 | 38 | 8 | 36089195 | |
| Pubmed | 4.40e-07 | 653 | 38 | 8 | 22586326 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 9.10e-07 | 989 | 38 | 9 | 36424410 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12663044 | ||
| Pubmed | Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse. | 1.16e-06 | 2 | 38 | 2 | 7774954 | |
| Pubmed | Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1). | 1.16e-06 | 2 | 38 | 2 | 18845576 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 20180799 | ||
| Pubmed | The dual role of helix-loop--helix-zipper protein USF in ribosomal RNA gene transcription in vivo. | 1.16e-06 | 2 | 38 | 2 | 9053857 | |
| Pubmed | Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. | 1.16e-06 | 2 | 38 | 2 | 8576131 | |
| Pubmed | Genetic association between USF 1 and USF 2 gene polymorphisms and Japanese Alzheimer's disease. | 1.16e-06 | 2 | 38 | 2 | 16870626 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9685363 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15242350 | ||
| Pubmed | Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. | 1.16e-06 | 2 | 38 | 2 | 8127680 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 7852331 | ||
| Pubmed | Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. | 1.16e-06 | 2 | 38 | 2 | 9520440 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 16386222 | ||
| Pubmed | USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. | 1.16e-06 | 2 | 38 | 2 | 17379962 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.57e-06 | 774 | 38 | 8 | 15302935 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19087304 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12611894 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18758746 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16199862 | ||
| Pubmed | USF-1 and USF-2 trans-repress IL-1beta-induced iNOS transcription in mesangial cells. | 3.48e-06 | 3 | 38 | 2 | 12225970 | |
| Pubmed | Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter. | 3.48e-06 | 3 | 38 | 2 | 21813151 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 23653383 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22547438 | ||
| Pubmed | Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. | 3.48e-06 | 3 | 38 | 2 | 12970752 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11945176 | ||
| Pubmed | Upstream stimulating factors regulate the expression of RORγT in human lymphocytes. | 3.48e-06 | 3 | 38 | 2 | 22891280 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15187018 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17823260 | ||
| Pubmed | Archaic structure of the gene encoding transcription factor USF. | 3.48e-06 | 3 | 38 | 2 | 7523363 | |
| Pubmed | Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma. | 3.48e-06 | 3 | 38 | 2 | 25149140 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 23749757 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18566134 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18167349 | ||
| Pubmed | Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen. | 3.48e-06 | 3 | 38 | 2 | 33001025 | |
| Pubmed | Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. | 3.48e-06 | 3 | 38 | 2 | 18165439 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19008453 | ||
| Pubmed | Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1. | 3.48e-06 | 3 | 38 | 2 | 15983197 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15767439 | ||
| Pubmed | 4.06e-06 | 98 | 38 | 4 | 18557763 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 23181698 | ||
| Pubmed | Combinatorial gene control involving E2F and E Box family members. | 6.96e-06 | 4 | 38 | 2 | 15014447 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 25040025 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 14644095 | ||
| Pubmed | Cooperative E-box regulation of human GLI1 by TWIST and USF. | 6.96e-06 | 4 | 38 | 2 | 11948912 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 12663664 | ||
| Pubmed | Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. | 6.96e-06 | 4 | 38 | 2 | 15780077 | |
| Pubmed | NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4. | 6.96e-06 | 4 | 38 | 2 | 12791656 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 18817855 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 14531897 | ||
| Pubmed | Interaction of USF1/USF2 and alpha-Pal/Nrf1 to Fmr-1 promoter increases in mouse brain during aging. | 6.96e-06 | 4 | 38 | 2 | 18782566 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 9890958 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 31256877 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 15864740 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 18762192 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 12917334 | ||
| Pubmed | 1.03e-05 | 709 | 38 | 7 | 22988430 | ||
| Pubmed | 1.14e-05 | 1014 | 38 | 8 | 32416067 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 22287717 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 12857727 | ||
| Pubmed | Antagonistic regulation of beta-globin gene expression by helix-loop-helix proteins USF and TFII-I. | 1.16e-05 | 5 | 38 | 2 | 16943425 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.17e-05 | 1353 | 38 | 9 | 29467282 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.23e-05 | 1024 | 38 | 8 | 24711643 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 15466854 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.38e-05 | 807 | 38 | 7 | 22681889 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 11724819 | ||
| Pubmed | 2.98e-05 | 332 | 38 | 5 | 25693804 | ||
| Pubmed | 3.24e-05 | 847 | 38 | 7 | 35850772 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 15358760 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.65e-05 | 605 | 38 | 6 | 28977666 | |
| Pubmed | A role of DNA-PK for the metabolic gene regulation in response to insulin. | 5.20e-05 | 10 | 38 | 2 | 19303849 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.30e-05 | 1257 | 38 | 8 | 36526897 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 6.15e-05 | 1284 | 38 | 8 | 17353931 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.71e-05 | 394 | 38 | 5 | 27248496 | |
| Pubmed | 7.21e-05 | 655 | 38 | 6 | 35819319 | ||
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 12907752 | ||
| Pubmed | Physical delineation of a 700-kb region overlapping the Looptail mutation on mouse chromosome 1. | 7.62e-05 | 12 | 38 | 2 | 9933565 | |
| Pubmed | Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function. | 9.00e-05 | 13 | 38 | 2 | 29114040 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 11230134 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.71e-05 | 220 | 38 | 4 | 35785414 | |
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 1.05e-04 | 14 | 38 | 2 | 28263302 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 15836771 | ||
| Pubmed | Structural basis and specificity of human otubain 1-mediated deubiquitination. | 1.21e-04 | 15 | 38 | 2 | 18954305 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.27e-04 | 1425 | 38 | 8 | 30948266 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.28e-04 | 89 | 38 | 3 | 22446626 | |
| Pubmed | 1.29e-04 | 1429 | 38 | 8 | 35140242 | ||
| Pubmed | 1.38e-04 | 1442 | 38 | 8 | 35575683 | ||
| Pubmed | 1.38e-04 | 241 | 38 | 4 | 23125841 | ||
| Pubmed | Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. | 1.56e-04 | 17 | 38 | 2 | 21653943 | |
| Pubmed | 1.61e-04 | 251 | 38 | 4 | 31076518 | ||
| Pubmed | 1.69e-04 | 1103 | 38 | 7 | 34189442 | ||
| Pubmed | 1.76e-04 | 99 | 38 | 3 | 19730683 | ||
| Pubmed | USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. | 1.76e-04 | 18 | 38 | 2 | 17846119 | |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.76e-04 | 18 | 38 | 2 | 25363768 | |
| Pubmed | Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. | 1.96e-04 | 19 | 38 | 2 | 16901790 | |
| Interaction | ACTC1 interactions | 4.30e-06 | 694 | 38 | 9 | int:ACTC1 | |
| Interaction | CFDP1 interactions | 1.46e-05 | 79 | 38 | 4 | int:CFDP1 | |
| Interaction | TOP1 interactions | 3.79e-05 | 696 | 38 | 8 | int:TOP1 | |
| Interaction | LZTS2 interactions | 4.18e-05 | 512 | 38 | 7 | int:LZTS2 | |
| Interaction | SIRT7 interactions | 6.08e-05 | 744 | 38 | 8 | int:SIRT7 | |
| Interaction | FHL2 interactions | 8.99e-05 | 396 | 38 | 6 | int:FHL2 | |
| Cytoband | 19q13 | 3.06e-04 | 31 | 38 | 2 | 19q13 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.04e-05 | 110 | 27 | 4 | 420 | |
| GeneFamily | DEAD-box helicases | 1.78e-03 | 42 | 27 | 2 | 499 | |
| GeneFamily | PHD finger proteins | 7.93e-03 | 90 | 27 | 2 | 88 | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 9.04e-07 | 199 | 38 | 6 | 4561_DN | |
| Drug | Prampine [inn:ban] | 1.62e-05 | 4 | 38 | 2 | CID003083997 | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.66e-05 | 193 | 38 | 5 | 4285_DN | |
| Drug | Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.79e-05 | 196 | 38 | 5 | 3547_DN | |
| Drug | cde1 | 4.05e-05 | 6 | 38 | 2 | CID000092428 | |
| Drug | palinavir | 5.67e-05 | 7 | 38 | 2 | CID000072981 | |
| Drug | O-Mn | 9.69e-05 | 9 | 38 | 2 | CID000448564 | |
| Drug | kalinin | 1.06e-04 | 55 | 38 | 3 | CID000032518 | |
| Drug | MBMP | 1.48e-04 | 11 | 38 | 2 | CID000150994 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.12e-04 | 177 | 38 | 4 | 6340_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.21e-04 | 179 | 38 | 4 | 5822_DN | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; HL60; HG-U133A | 2.31e-04 | 181 | 38 | 4 | 1613_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.72e-04 | 189 | 38 | 4 | 5084_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.78e-04 | 190 | 38 | 4 | 5579_UP | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 2098_DN | |
| Drug | Chloroprene | 2.97e-04 | 1348 | 38 | 9 | ctd:D002737 | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 5362_UP | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 7164_UP | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 6921_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 6835_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4169_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 3452_UP | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 2962_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3069_DN | |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 7409_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2158_DN | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; HL60; HG-U133A | 3.13e-04 | 196 | 38 | 4 | 1546_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2531_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3783_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 5111_UP | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 4656_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; HL60; HG-U133A | 3.13e-04 | 196 | 38 | 4 | 1770_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 1819_DN | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1718_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 5244_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 5499_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1485_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1385_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3442_UP | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3226_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2526_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.19e-04 | 197 | 38 | 4 | 1048_UP | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1842_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3930_DN | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 5729_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2294_UP | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 1812_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4529_UP | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3087_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3441_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2730_DN | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4428_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4282_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3995_UP | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; HL60; HG-U133A | 3.25e-04 | 198 | 38 | 4 | 1963_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 5253_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3325_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3117_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4095_UP | |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 1489_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; HL60; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 3089_DN | |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | 3.31e-04 | 199 | 38 | 4 | 578_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 2341_UP | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; HL60; HG-U133A | 3.31e-04 | 199 | 38 | 4 | 1719_DN | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.38e-04 | 200 | 38 | 4 | 4082_DN | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; MCF7; HT_HG-U133A | 3.38e-04 | 200 | 38 | 4 | 7444_UP | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; HL60; HG-U133A | 3.38e-04 | 200 | 38 | 4 | 1980_UP | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 8.82e-05 | 11 | 38 | 2 | cv:CN043612 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 1.25e-04 | 13 | 38 | 2 | cv:C4273714 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 6.87e-04 | 30 | 38 | 2 | C1868672 | |
| Disease | chronic rhinosinusitis | 8.83e-04 | 34 | 38 | 2 | EFO_1000024 | |
| Disease | migraine disorder | 1.12e-03 | 357 | 38 | 4 | MONDO_0005277 | |
| Disease | hematocrit | 1.72e-03 | 1011 | 38 | 6 | EFO_0004348 | |
| Disease | pulse pressure measurement | 1.79e-03 | 1392 | 38 | 7 | EFO_0005763 | |
| Disease | mean platelet volume | 1.80e-03 | 1020 | 38 | 6 | EFO_0004584 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.83e-03 | 49 | 38 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 2.22e-03 | 54 | 38 | 2 | C0149925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNRQLEREKRREHSR | 1271 | Q9UKV3 | |
| DKERRHRRRKENQGS | 1021 | O00555 | |
| RRERARQRHAEKLAA | 441 | Q7Z2Z2 | |
| RRLERLDHLAEKFRQ | 406 | O43707 | |
| FLRERNKHLRDERDI | 371 | Q9BSW2 | |
| RAERFRIQEEHREAK | 896 | Q92625 | |
| SEDEQHFERRRKRSR | 366 | Q6PL18 | |
| FAERVRQRDKDRTRN | 181 | O60231 | |
| EQEKHELRRRFENRE | 146 | Q6ZP65 | |
| KRLEHTERQFRNRRK | 46 | Q8IY67 | |
| REHGERRRKFEFDLR | 241 | O75420 | |
| AKRRREEARQRDQEF | 666 | Q8TDD1 | |
| KRLQENLRREAFREH | 171 | Q96J88 | |
| RLFLMDREERRQREH | 226 | Q5CZC0 | |
| DREERRQREHTRRKL | 231 | Q5CZC0 | |
| RRRTRHLNDRKFVFE | 261 | Q9BUQ8 | |
| RQRRRQSKEQDEVRH | 406 | O94988 | |
| EKHEERVPRERRQRQ | 841 | O94880 | |
| EHQRDRQKRREERRL | 426 | Q8IZP7 | |
| KDLQHLSREERRRRR | 56 | Q02575 | |
| PNDLRHDIERRRKER | 551 | A2AJT9 | |
| QFELKQHEFRERFRR | 1206 | Q9UFH2 | |
| ERHNRLEERKRQRKE | 786 | Q14152 | |
| FRRRDRAHREIKDIF | 256 | Q16850 | |
| RKNRKRHREPQEDLR | 126 | Q86VF2 | |
| RNEKRFHRQAAEEIR | 241 | O43781 | |
| RIFREKQHEERRLKD | 366 | Q9C093 | |
| RHHEEQRQKEERARR | 171 | Q6ZRS2 | |
| EDLRRRHREQERKLQ | 911 | Q9UPV0 | |
| HNFLERKRRNDLRSR | 286 | P12524 | |
| RRRHDDKEKLLADQR | 731 | Q9BX66 | |
| ERRFSRSDQLKRHQR | 361 | P19544 | |
| QESERHRRRDRSQDK | 1941 | Q92576 | |
| RRAQHNEVERRRRDK | 236 | Q15853 | |
| HRDFDVEKRLRRDLR | 1791 | Q8IUG5 | |
| RFNIHNNRKRRRDSD | 1041 | Q96KR1 | |
| QERDRKFREEELRHQ | 1356 | Q07283 | |
| EEQQLRQERHRKFRE | 1451 | Q07283 | |
| RQERHRKFREEEQLL | 1456 | Q07283 | |
| REEQQLHRQERDRKF | 1631 | Q07283 | |
| EREQQLRHDRDRKFR | 1656 | Q07283 | |
| LRHDRDRKFREEEQL | 1661 | Q07283 | |
| NFEREFKNRKRHTRR | 576 | Q8IYH5 | |
| RDEKRRAQHNEVERR | 196 | P22415 | |
| RAQHNEVERRRRDKI | 201 | P22415 |